Login / Signup

Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply.

A A ShaheenM Al-MattooqS YazdanfarK W BurakM G SwainS E ConglyM A BormanS S LeeR P MyersCarla S Coffin
Published in: Alimentary pharmacology & therapeutics (2017)
Keyphrases
  • hepatitis b virus
  • antiretroviral therapy